about
Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition.Estimating quality adjusted progression free survival of first-line treatments for EGFR mutation positive non small cell lung cancer patients in The NetherlandsGefitinib in combination with prednisolone to avoid interstitial lung disease during non-small cell lung cancer treatment: A case report.Advances in the proteomic discovery of novel therapeutic targets in cancer.Tumor control versus adverse events with targeted anticancer therapies.Molecular Targeting of Growth Factor Receptor Signaling in Radiation Oncology.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Geftinib.
@en
Geftinib.
@nl
type
label
Geftinib.
@en
Geftinib.
@nl
prefLabel
Geftinib.
@en
Geftinib.
@nl
P356
P1476
Geftinib.
@en
P2093
Ajay Gupta
Vinod Raina
P304
P356
10.4103/0973-1482.73330
P407
P577
2010-07-01T00:00:00Z